These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 10975864

  • 1. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B, Kashgarian MJ, Sharpe AH, Mamula MJ.
    J Immunol; 2000 Sep 15; 165(6):3436-43. PubMed ID: 10975864
    [Abstract] [Full Text] [Related]

  • 2. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ.
    J Immunol; 1999 Aug 15; 163(4):2322-9. PubMed ID: 10438978
    [Abstract] [Full Text] [Related]

  • 3. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice.
    Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR.
    J Immunol; 2000 Jun 01; 164(11):6046-56. PubMed ID: 10820290
    [Abstract] [Full Text] [Related]

  • 4. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 5. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 6. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.
    J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922
    [Abstract] [Full Text] [Related]

  • 7. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS.
    Kidney Int; 2004 Jan 15; 65(1):129-38. PubMed ID: 14675043
    [Abstract] [Full Text] [Related]

  • 8. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 15; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 9. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
    Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW.
    J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582
    [Abstract] [Full Text] [Related]

  • 10. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice.
    Sekine H, Watanabe H, Gilkeson GS.
    J Immunol; 2004 Mar 15; 172(6):3913-21. PubMed ID: 15004199
    [Abstract] [Full Text] [Related]

  • 11. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.
    Jiang C, Foley J, Clayton N, Kissling G, Jokinen M, Herbert R, Diaz M.
    J Immunol; 2007 Jun 01; 178(11):7422-31. PubMed ID: 17513793
    [Abstract] [Full Text] [Related]

  • 12. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
    Satoh M, Weintraub JP, Yoshida H, Shaheen VM, Richards HB, Shaw M, Reeves WH.
    J Immunol; 2000 Jul 15; 165(2):1036-43. PubMed ID: 10878381
    [Abstract] [Full Text] [Related]

  • 13. Lupus nephritis in the absence of renal major histocompatibility complex class I and class II molecules.
    Mukherjee R, Zhang Z, Zhong R, Yin ZQ, Roopenian DC, Jevnikar AM.
    J Am Soc Nephrol; 1996 Nov 15; 7(11):2445-52. PubMed ID: 8959638
    [Abstract] [Full Text] [Related]

  • 14. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
    Zeller GC, Hirahashi J, Schwarting A, Sharpe AH, Kelley VR.
    J Am Soc Nephrol; 2006 Jan 15; 17(1):122-30. PubMed ID: 16291836
    [Abstract] [Full Text] [Related]

  • 15. CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production.
    Shi L, Bian Z, Chen CX, Guo YN, Lv Z, Zeng C, Liu Z, Zen K, Liu Y.
    J Pathol; 2015 Nov 15; 237(3):285-95. PubMed ID: 26095930
    [Abstract] [Full Text] [Related]

  • 16. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS.
    J Immunol; 2000 Jan 15; 164(2):786-94. PubMed ID: 10623824
    [Abstract] [Full Text] [Related]

  • 17. Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice.
    Zhou Y, Chen H, Liu L, Yu X, Sukhova GK, Yang M, Kyttaris VC, Stillman IE, Gelb B, Libby P, Tsokos GC, Shi GP.
    J Immunol; 2017 Mar 01; 198(5):1846-1854. PubMed ID: 28093526
    [Abstract] [Full Text] [Related]

  • 18. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
    Yan J, Mamula MJ.
    Int Immunol; 2002 Aug 01; 14(8):963-71. PubMed ID: 12147633
    [Abstract] [Full Text] [Related]

  • 19. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.
    Fatenejad S, Brooks W, Schwartz A, Craft J.
    J Immunol; 1994 Jun 01; 152(11):5523-31. PubMed ID: 7514640
    [Abstract] [Full Text] [Related]

  • 20. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb 01; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.